Quidel

SAN DIEGO, CA -- (Marketwire) -- 04/13/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release first quarter 2012 financial results after market close on Wednesday, April 25, 2012. Following the release of results, Douglas Bryant, president and chief ... read more

SAN DIEGO, CA -- (Marketwire) -- 04/02/12 -- Quidel Corporation (NASDAQ: QDEL) announced today that it received CE mark for the Quidel Molecular™ Direct C. difficile Tox A/B assay for the detection of toxigenic Clostridium difficile bacterial DNA. C. difficile infection is frequently associated with antibiotic therapy and ... read more

SAN DIEGO, CA -- (Marketwire) -- 03/27/12 -- Quidel Corporation (NASDAQ: QDEL), announced today that it received CE mark for the AmpliVue C. difficile assay, its non-instrumented molecular test for the detection of toxigenic Clostridium difficile bacterial DNA. Detection of the pathogen is achieved using a hand-held fully ... read more

SAN DIEGO, CA -- (Marketwire) -- 03/22/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of diagnostic testing solutions, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Quidel Molecular™ Influenza A+B Assay for the detection of influenza ... read more

SAN DIEGO, CA -- (Marketwire) -- 03/12/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cell-based virology assays, announced today that it has received the CE Mark for the Quidel Molecular™ RSV + hMPV assay for the detection of respiratory syncytial virus ... read more

SAN DIEGO, CA -- (Marketwire) -- 02/02/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release fourth quarter and full year 2011 financial results after market close on Wednesday, February 29, 2012. Following the release of results, Douglas Bryant, ... read more

SAN DIEGO, CA -- (Marketwire) -- 01/04/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, announced today that it will present at the 30th Annual J.P. Morgan Health Care Conference to be held at The Westin St. Francis hotel ... read more

SAN DIEGO, CA -- (Marketwire) -- 11/18/11 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, announced today that it will present at the 23rd Annual Piper Jaffray Health Care Conference to be held at The New York Palace Hotel ... read more

SAN DIEGO, CA -- (Marketwire) -- 11/02/11 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of diagnostic testing solutions, announced today that it will present at the Credit Suisse 2011 Health Care Conference to be held at the Arizona Biltmore hotel in Phoenix, Arizona on Wednesday, November 9, ... read more

SAN DIEGO, CA -- (Marketwire) -- 10/04/11 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release third quarter 2011 financial results after market close on Tuesday, October 25, 2011. Following the release of results, Douglas Bryant, president and chief ... read more

SAN DIEGO, CA -- (Marketwire) -- 09/21/11 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cell-based virology assays, announced today that it has received the CE Mark for the Quidel® Molecular hMPV Real-Time RT-PCR Assay. This assay is Quidel's second molecular diagnostic ... read more

SAN DIEGO, CA -- (Marketwire) -- 08/16/11 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cell-based virology assays, announced today that it has received the CE Mark for its Sofia® Fluorescent Immunoassay Analyzer and for its Sofia® Influenza A+B Fluorescent Immunoassay (FIA). Sofia ... read more

SAN DIEGO, CA -- (Marketwire) -- 08/05/11 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, announced today that it has received the CE Mark for the Quidel® Molecular Influenza A+B Real-Time RT-PCR Assay -- its first molecular diagnostic test. This is the first ... read more

SAN DIEGO, CA -- (Marketwire) -- 07/19/11 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release second quarter 2011 financial results after market close on Tuesday, August 2, 2011. Following the release of results, Douglas Bryant, president and chief ... read more

SAN DIEGO, CA -- (Marketwire) -- 05/05/11 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, announced today that it will present at the Bank of America Merrill Lynch Health Care Conference to be held at the Encore at Wynn ... read more

SAN DIEGO, CA -- (Marketwire) -- 04/15/11 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, will release first quarter 2011 financial results after market close on Thursday, April 28, 2011. Following the release of results, Douglas Bryant, president and chief executive officer, and John ... read more